Purine enzyme activities are usually assayed by radiochemical procedures and often TLC is part of the separation method. In screening patients with rheumatic diseases, these procedures have shown disadvantages like a relatively large coefficient of variation (C.V.) and time-instability. We describe a non-radiochemical reversed-phase HPLC micro-method with UV detection for measurement of activities of purine S'-nuclcotidase (5'NT; EC 3.1.3.5), purine nucleoside phosphorylase (PNP; EC 2.4.2.1) and hypoxanthine guanine phosphoribosyltransferase (HGPRT; EC 2.4.2.8) in human peripheral blood mononuclear cells (PBMC). The HPLC procedure is compared with the radiochemical TLC procedure by testing both with a 5'NT and a PNP assay. Reproducibility is tested with 14 healthy controls in each procedure. Short-term and long-term time-stability is tested by comparing enzyme activities measured immediately after preparation of the PBMC (week 0) with those found after freezing and storage at " 20°C for a maximum of 10 weeks. The HPLC procedure is preferable to the radiochemical TLC procedure because it shows significantly better reproducibility and better time-stability and in addition is non-radiochemical and less time-consuming.
Introduction
Purine enzymes play an important role in physiological as well as in pathological condi tions. Several immunodeficiencies are related to abnormalities of purine enzyme activities [1] [2] [3] [4] [5] [6] [7] . Impairment of purine enzyme activities is also used in the treatment of a number of autoim mune diseases and malignancies and to prevent allograft rejection in organ transplant recipients. The outcome of A Z A treatment may be strongly influenced by deficiencies of purine enzymes: HGPRT deficiency causes resistance to AZA treatment [13] and both thiopurine methyltransferase deficiency and low levels of 5'NT result in increased susceptibility to severe bone marrow depression during A ZA treatment [14] [15] [16] [17] .
Purine enzyme activities are often measured by radiochemical procedures in combination with TLC separation. During a recent screening of purine metabolism in patients with RA, we found some distinct disadvantages of these pro cedures. Firstly, time-stability of enzyme ac tivities of the freeze-dried PBMC stored at -20°C was not as expected. Secondly, the C.V. was relatively large. Thirdly, regarding environ mental protection, radiation hygienics and gener al applicability, radiochemical assays are out of favour nowadays, and finally, these procedures are rather time-consuming.
According to a Medline literature search start ing from 1982 there are no previous reports comparing a radiochemical TLC procedure with a non-radiochemical HPLC procedure to mea sure activities of the purine enzymes 5'NT and PNP, nor reports of HPLC procedures to mea sure purine enzyme activities of 5'NT, PNP or HGPRT in human PBMC.
In this paper we present a new non-radio chemical reversed-phase HPLC micro-method which obviates the above-mentioned disadvan tages. Reproducibility and time-stability were tested with PNP and 5'NT assays using both procedures. Time-stability of the HPLC proce dure was also tested with an HGPRT assay. Tests were carried out with blood samples from healthy volunteers. All enzyme assays were carried out in quad ruplicate,
Experimental

Isolation o f mononuclear cells from peripheral blood
A 10-ml volume of venous blood was defibrinated (on glass beads) as soon as it was obtained and immediately processed for further analysis. An equal volume of 0.9% (w/v) NaCl (NPBI) was added and 8 ml of this suspension was carefully layered on top of a density gradient, containing 4 ml Ficoll-Isopaque (density 1.077 g/ml, Nycomed), Centrifugation (Sorvall RC3, DuPont Company, Newtown, CT, USA) was carried out at room temperature for 20 min at 1000 g . PBMC were collected from the interface, washed with approximately the same volume of 0.9% NaCl and centrifuged (Hettich Universal 30 RF, Hettich Zentrifugen, Tuttlingen, Ger many) at 20°C for 5 min at 825 g. The con taminating erythrocytes were eliminated by resuspending the cell pellet in a 10-ml erythrocyte shock solution consisting of 170 mM Tris The cells were frozen at ~70°C and lyophilized overnight (Lyovac GT2, Leybold, Köln, Ger many). For the radiochemical TLC procedure the pretreated cells were stored at -20°C until the enzyme assay was carried out. For the HPLC procedure, the enzyme assays were performed the next day and the supernatants were stored at -20°C until the HPLC separation. The enzyme assays, the TLC separation meth ods and the calculation of specific enzyme ac tivities were carried out essentially according to procedures published previously [18] . PNP activity was determined from the conver sion of hypoxanthine to inosine:
PNP
Hypoxanthine + R -l-P --------> inosine + P¡ (2)
The reaction mixture had a pH of 7.0 and consisted of 4 nm ol/10 /¿I hypoxanthine (Sigma), 5 mM ribose-l-phosphate (R -l-P) (Sigma), 0.5 M Tris+ 10 mAÍ EDTA (Siegfried S.A .) and 10% Triton X-100 (10:10:10:1, v/v). Of this mixture 20 /xl were added to the lyophilized PBMC. The reaction was allowed to proceed for 1 h at 37°C. The incubation mixture was de proteinized, neutralized and stored according to the method used for the purine 5'-nucleotidase assay.
Hypoxanthine-guanine phosphoribosyltransferase.
HGPRT activity was determined from the conversion of hypoxanthine to inosine mono phosphate (IMP): Fig. 1) . The method previ ously published [19] was modified slightly.
Hypoxanthine + PRPP--------------> IMP + inosine
The incubation mixture stored at -20°C was thawed and centrifuged at 20°C for 4 min at 17 000 g. Twenty microliters of the supernatant were injected onto the HPLC system.
Control preparations consisted of two blanks, the reaction mixture (A) and a combination of reaction mixture plus isolated enzyme without substrate (B), and three standard solutions. For each type of enzyme assay a specific own blank A was analyzed. A blank B was analyzed with the HPLC procedure for each enzyme assay per person. The three standard solutions were mea sured per ten samples. The standard solutions contained all six purine nucleotides and nu cleosides, each of them in three concentrations.
Calculation o f specific enzyme activity
For each substrate and each product a stan dard curve of the peak area against the con centration was made. After separation, the con centration of the products could be determined from their area under the curve value. The specific enzyme activity was calculated and ex pressed in nmol/106 viable cells/h. 
Buffer
Statistics
To analyze the reproducibility of both the radiochemical TLC and the HPLC procedure, the C.V. for the PNP assay and the 5'NT assay was calculated from the data-set of each control subject. The differences between the procedures, regarding the mean C.V., were examined by using the non-parametric two-sided Wilcoxon rank-sum test.
Differences in time-stability were analyzed on the basis of a fixed two-way analysis of variance (ANOVA) model with fixed patient effects and a mixed two-way ANOVA model with random patient effects. Additionally pairwise differences between times were analyzed further according to the multiple comparison method of Scheffé [20] . Analysis of the reproducibility of PNP activity and 5'NT activity measured by both methods was carried out as described above. All pro cedures were performed within the first two weeks after blood sampling. The results are given in Table 1 enzyme activity at certain time intervals of either a sample of the pretreated and stored PBMC (radiochemical TLC procedure) or a sample of the stored supernatant of the deproteinized incu bation mixture (HPLC procedure). The 5'NT assay measured by the radiochemi cal TLC procedure (Fig. 4) is not stable in time. According to a fixed two-way ANOVA, averaged over the 5 persons, not all time means were equal (p < 0.001). This is caused mainly by a significant decrease between week 0 and the subsequent weeks. During the following weeks there is a decreasing trend in averaged 5'NT enzyme activities. Examining the data on the basis of a two-way mixed ANOVA model with random patient effects, followed by a multiple comparison procedure of Scheffé (data not shown), the same conclusions could be drawn.
For PNP assayed by the radiochemical TLC procedure, the hypothesis of equal time means, averaged over the 5 persons, also has to be rejected ( p < 0.001). A nearly significant de crease was found between week 0 and weeks 1, 3, 6 and 8 (Fig. 4) . However, at week 2, the enzyme activity is again at the level measured before freezing the PBMC. Under the mixed two-way ANOVA model (data not shown) the differences are somewhat less distinct but still point in the same direction.
As regards the 5'NT assay tested by the HPLC procedure, the hypothesis of equal time means, averaged over 3 persons, has to be rejected ( p < 0.001) too. No average differences were found between weeks 1, 2, 8 and 10 (Fig, 4) , but enzyme activity in week 0 is significantly higher than during the following weeks. The mixed two-way ANOVA model with random patient effects, followed by a multiple comparison pro cedure of Scheffé (data not shown) gives the same result and also points to an effect of freezing.
The PNP assay measured by the HPLC pro cedure is very stable. On average all weeks have about the same enzyme activity (p > 0.10) (Fig. 
4).
Concerning the HGPRT assay, averaged over the 3 persons, the time means show no equality ( p < 0.001). However, only at week 8 a sig- nificantly higher mean is found compared with the other times (p ^ 0.05) (Fig. 4) . The two-way mixed ANOVA model showed no differences among all the weeks, indicating that the impair ment at week 8 is only a minor effect, probably not important in studies testing larger groups. Finally it is noted that for 5'NT and PNP assayed by the radiochemical TLC procedure and for HGPRT assayed by the HPLC pro cedure, the different persons do not show paral lel time profiles (interaction tests of the fixed two-way ANOVA yielding p = 0.001, p = 0.02 and p = 0.02 respectively).
Discussion
Screening large numbers of patients for their purine enzyme activities often causes difficulties in planning and questions about feasibility because the laboratory procedures are rather complicated and time-consuming. These prob lems might be overcome if the laboratory pro cedure could be interrupted and the patient material temporarily stored without effect on the enzyme activities measured.
In this way the time stability of the radio chemical TLC procedure was tested when it was interrupted after isolation, purification, division and lyophilization of the PBMC. The results were disappointing, because of a gradual de crease of 5'NT enzyme activity. Possibly this was due to decrease of ecto-5'-nucleotidase activity. The localization on the outside of the cell mem brane could make this enzyme more sensitive to manipulation of the cells than cytoplasmatic enzymes. It is obvious that freezing and storing at -20°C of prepared mononuclear cells is not adequate to preserve 5'NT purine enzyme activi ty for a longer period of time. Therefore in our study design this radiochemical TLC procedure is not acceptable.
The PNP assay in the radiochemical TLC procedure shows a more stable enzyme activity during the 8 weeks with two exceptions. The higher enzyme activity at week 0 indicates a possible effect of freezing. No adequate explana tion can be given of the significantly higher activity in week 2. It is very unlikely that enzyme activities return to pre-freezing levels. Although activity of week 2 seems to be significantly higher, it still falls within the range of the standard deviations, so these values may be coincidental and part of the normal fluctuations of this procedure.
The TLC procedure itself may also play an important role in the moderate results. The separation between substrate and products is not always very sharp and may cause minor errors when the several zones have to be cut out for fluid scintillation counting. By doing so another source of inaccuracy of the results is the crum- Apart from the separation itself the three main differences between the radiochemical TLC and the HPLC procedure are, firstly, the larger number of cells used in the HPLC procedure while it still remains a micro-method; secondly, after lyophilization of the PBMC essential steps (storage, incubation and separation) have a dif ferent sequence in the HPLC procedure; and, thirdly, the incubation is terminated by protein dénaturation instead of cooling on ice.
-
The enzymatic conditions of 5'NT, PNP and HGPRT in the HPLC procedure are largely based on those of the radiochemical TLC pro cedure, Each enzyme assay displays a good linearity between enzyme activity and a wide range of cell numbers. Results of recovery ex periments were good as well, and a sharp sepa ration of mononucleotides and nucleosides was achieved in a total run-time of 25 min.
The reproducibility of the HPLC procedure is significantly better than that of the radiochemical TLC procedure, for both the PNP assay and 5'NT assay. Smaller differences in purine en zyme activities will be significant sooner in this HPLC procedure and with respect to our studies of purine enzyme activities in patients with rheumatic diseases [12, 17] , this is an important advantage.
Time-stability of the HPLC procedure was tested in short-term and long-term follow-up. The test with the 5'NT assay shows a clear effect between week 0 and the other weeks, indicating that freezing at -20°C of the supernatant has still a decreasing effect on 5'NT activity mea sured. Because this procedure rules out a freez ing and storing effect on the enzyme itself the cause has to be located on the level of substrate (AMP) and/or product [adenosine, (inosine and hypoxanthine)]. Apart from the freezing and storing effect on the enzyme itself this hitherto unnoticed influence on substrate and/or product may also play an additional role in the decreas ing 5'NT activity assayed by the radiochemical TLC procedure.
Interestingly, the PNP assay measured by the HPLC procedure has a very good time-stability, in the short as well as in the long term.
HPLC time-stability tested for the HGPRT assay is good, with an unexpected exception in week 8. This is probably merely a coincidental error and according to the statistical tests not important in larger studies.
In conclusion we can say that the non-radiochemical HPLC procedure presented has a far better separation capacity for the nucleosides and mononucleotides tested than the radio chemical TLC procedure. Measurements of ac tivities of the purine enzymes 5'NT and PNP by the HPLC procedure are highly reproducible and the time-stability of the HPLC procedure is also better. To guarantee time-stability in the HPLC procedure, 5'NT measurements should be car ried out after freezing and storing of the pre pared sample, whereas these factors have no influence on the measurement of PNP and HGPRT activity. Since the HPLC procedure is non-radiochemical, it complies better with cur rent environmental protection policies and makes it applicable in common clinical laborator ies. Finally this procedure is less time-consuming and more practical when larger numbers of persons have to be screened.
